The global Doxorubicin Market is witnessing steady growth, supported by the increasing prevalence of cancer and the growing preference for chemotherapy treatments worldwide. The market size is projected to reach US$ 2.35 billion by 2031 from US$ 1.47 billion in 2023. The market is expected to register a compound annual growth rate (CAGR) of 6.1% during 2023–2031. Increasing demand for...